Aripiprazole Augmentation to Mood Stabilizers for Obsessive-Compulsive Symptoms in Bipolar Disorder

Background and Objectives: Aripiprazole is a first-line agent in the treatment of bipolar disorder (BD) and available data demonstrates its efficacy on clinical symptoms in serotonin reuptake inhibitors-resistant obsessive-compulsive disorder (OCD) patients. Therefore, aripiprazole augmentation to m...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Salvo, Gabriele, Maina, Giuseppe, Pessina, Enrico, Teobaldi, Elena, Barbaro, Francesca, Martini, Azzurra, Albert, Umberto, Rosso, Gianluca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824272/
https://www.ncbi.nlm.nih.gov/pubmed/33374357
http://dx.doi.org/10.3390/medicina57010009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824272/
https://www.ncbi.nlm.nih.gov/pubmed/33374357
http://dx.doi.org/10.3390/medicina57010009

Ejemplares similares